位置:首页 > 蛋白库 > YEDK_ECOLI
YEDK_ECOLI
ID   YEDK_ECOLI              Reviewed;         222 AA.
AC   P76318; Q2MB05;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 2.
DT   03-AUG-2022, entry version 128.
DE   RecName: Full=Abasic site processing protein YedK;
DE            EC=3.4.-.- {ECO:0000250|UniProtKB:Q8R1M0};
GN   Name=yedK {ECO:0000303|PubMed:29020633}; Synonyms=yedG;
GN   OrderedLocusNames=b1931, JW1916;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=JA11;
RX   PubMed=8371104; DOI=10.1099/00221287-139-7-1401;
RA   Raha M., Kihara M., Kawagishi I., Macnab R.M.;
RT   "Organization of the Escherichia coli and Salmonella typhimurium
RT   chromosomes between flagellar regions IIIa and IIIb, including a large non-
RT   coding region.";
RL   J. Gen. Microbiol. 139:1401-1407(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=16397293; DOI=10.1093/nar/gkj405;
RA   Riley M., Abe T., Arnaud M.B., Berlyn M.K.B., Blattner F.R.,
RA   Chaudhuri R.R., Glasner J.D., Horiuchi T., Keseler I.M., Kosuge T.,
RA   Mori H., Perna N.T., Plunkett G. III, Rudd K.E., Serres M.H., Thomas G.H.,
RA   Thomson N.R., Wishart D., Wanner B.L.;
RT   "Escherichia coli K-12: a cooperatively developed annotation snapshot
RT   -- 2005.";
RL   Nucleic Acids Res. 34:1-9(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   IDENTIFICATION.
RX   PubMed=23945014; DOI=10.1186/1745-6150-8-20;
RA   Aravind L., Anand S., Iyer L.M.;
RT   "Novel autoproteolytic and DNA-damage sensing components in the bacterial
RT   SOS response and oxidized methylcytosine-induced eukaryotic DNA
RT   demethylation systems.";
RL   Biol. Direct 8:20-20(2013).
RN   [6]
RP   ACTIVITY IN VITRO.
RX   PubMed=29020633; DOI=10.1016/j.celrep.2017.09.055;
RA   Kweon S.M., Zhu B., Chen Y., Aravind L., Xu S.Y., Feldman D.E.;
RT   "Erasure of Tet-Oxidized 5-Methylcytosine by a SRAP Nuclease.";
RL   Cell Rep. 21:482-494(2017).
RN   [7]
RP   FUNCTION, AND DNA-BINDING.
RX   PubMed=30554877; DOI=10.1016/j.cell.2018.10.055;
RA   Mohni K.N., Wessel S.R., Zhao R., Wojciechowski A.C., Luzwick J.W.,
RA   Layden H., Eichman B.F., Thompson P.S., Mehta K.P.M., Cortez D.;
RT   "HMCES maintains genome integrity by shielding abasic sites in single-
RT   strand DNA.";
RL   Cell 176:144-153(2019).
RN   [8] {ECO:0007744|PDB:6NUA, ECO:0007744|PDB:6NUH}
RP   X-RAY CRYSTALLOGRAPHY (1.59 ANGSTROMS) OF 2-222 IN COMPLEX WITH A DNA
RP   ABASIC SITE, THIAZOLIDINE LINKAGE TO A DNA ABASIC SITE, FUNCTION, CATALYTIC
RP   ACTIVITY, ACTIVE SITE, DOMAIN, AND MUTAGENESIS OF CYS-2; ASN-75; GLU-105
RP   AND HIS-160.
RX   PubMed=31235915; DOI=10.1038/s41594-019-0255-5;
RA   Thompson P.S., Amidon K.M., Mohni K.N., Cortez D., Eichman B.F.;
RT   "Protection of abasic sites during DNA replication by a stable thiazolidine
RT   protein-DNA cross-link.";
RL   Nat. Struct. Mol. Biol. 26:613-618(2019).
RN   [9] {ECO:0007744|PDB:6KBS, ECO:0007744|PDB:6KBU, ECO:0007744|PDB:6KBX, ECO:0007744|PDB:6KBZ, ECO:0007744|PDB:6KCQ, ECO:0007744|PDB:6KIJ}
RP   X-RAY CRYSTALLOGRAPHY (1.22 ANGSTROMS) OF 2-222 IN COMPLEX WITH A DNA
RP   ABASIC SITE, THIAZOLIDINE LINKAGE TO A DNA ABASIC SITE, FUNCTION, CATALYTIC
RP   ACTIVITY, ACTIVE SITE, DOMAIN, REACTION MECHANISM, AND MUTAGENESIS OF
RP   CYS-2; ARG-4; PRO-40; TRP-67; TRP-68; LYS-70; ASN-75; ARG-77; THR-80;
RP   SER-84; ARG-85; GLU-105; TRP-106; LYS-113; THR-149; HIS-160 AND ARG-162.
RX   PubMed=31504793; DOI=10.1093/nar/gkz744;
RA   Wang N., Bao H., Chen L., Liu Y., Li Y., Wu B., Huang H.;
RT   "Molecular basis of abasic site sensing in single-stranded DNA by the SRAP
RT   domain of E. coli yedK.";
RL   Nucleic Acids Res. 47:10388-10399(2019).
CC   -!- FUNCTION: Sensor of abasic sites in single-stranded DNA (ssDNA)
CC       required to preserve genome integrity by promoting error-free repair of
CC       abasic sites (PubMed:30554877). Recognizes and binds abasic sites in
CC       ssDNA at replication forks and chemically modifies the lesion by
CC       forming a covalent cross-link with DNA: forms a stable thiazolidine
CC       linkage between a ring-opened abasic site and the alpha-amino and
CC       sulfhydryl substituents of its N-terminal catalytic cysteine residue
CC       (PubMed:30554877, PubMed:31235915, PubMed:31504793). May act as a
CC       protease: mediates autocatalytic processing of its N-terminal
CC       methionine in order to expose the catalytic cysteine (By similarity).
CC       {ECO:0000250|UniProtKB:Q8R1M0, ECO:0000269|PubMed:30554877,
CC       ECO:0000269|PubMed:31235915, ECO:0000269|PubMed:31504793}.
CC   -!- DOMAIN: Glu-105 is involved in sensing abasic sites in single-stranded
CC       DNA (ssDNA) (PubMed:31504793). His-160 stabilizes the abasic sites by
CC       forming a hydrogen bond with the O4' hydroxyl group (PubMed:31235915).
CC       {ECO:0000269|PubMed:31235915, ECO:0000269|PubMed:31504793}.
CC   -!- MISCELLANEOUS: The thiol group of the catalytic Cys-2 is deprotonated
CC       by its alpha-amino group to form a thiolate anion that is poised for
CC       catalysis (PubMed:31504793). The abasic site sugar moiety is in
CC       equilibrium between its cyclic furanose and open-chain aldehyde forms
CC       (PubMed:31504793). The Cys-2 thiolate anion attacks the abasic site C1'
CC       position to form a covalent bond (PubMed:31504793). The Cys-2 alpha-
CC       amino group proton then transfers to the oxygen which is stabilized by
CC       the Asn-75 side chain (PubMed:31504793). The O4' rotates to a new
CC       position and interacts with the His-160 side chain (PubMed:31504793).
CC       The Cys-2 alpha-amino group then attacks the C1' position and transfers
CC       a proton to the hydroxyl group to release a water molecule, meanwhile
CC       forming a covalent bond with the C1' atom (PubMed:31504793). Thus, a
CC       thiazolidine linkage is formed between the abasic site C1' atom and the
CC       Cys-2 amino and thiol groups (PubMed:31504793). The Glu-105 side chain
CC       carboxyl stabilizes the thiazolidine linkage via a strong hydrogen bond
CC       with its amine group (PubMed:31504793). {ECO:0000269|PubMed:31504793}.
CC   -!- SIMILARITY: Belongs to the SOS response-associated peptidase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was reported to act as an endonuclease that specifically
CC       cleaves 5-hydroxymethylcytosine (5hmC)-containing DNA in vitro
CC       (PubMed:29020633). Additional experiments are however required to
CC       confirm this activity as this protein is present in many organisms that
CC       do not utilize methylcytosine for epigenetic control.
CC       {ECO:0000269|PubMed:29020633, ECO:0000305|PubMed:30554877}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L13279; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U00096; AAT48139.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76551.1; -; Genomic_DNA.
DR   PIR; H64956; H64956.
DR   RefSeq; WP_000334583.1; NZ_LN832404.1.
DR   RefSeq; YP_025310.1; NC_000913.3.
DR   PDB; 2ICU; X-ray; 1.60 A; A/B=1-222.
DR   PDB; 6KBS; X-ray; 1.60 A; B=2-222.
DR   PDB; 6KBU; X-ray; 2.10 A; A/B=2-222.
DR   PDB; 6KBX; X-ray; 1.22 A; B=2-222.
DR   PDB; 6KBZ; X-ray; 1.65 A; B/D/F/H=2-222.
DR   PDB; 6KCQ; X-ray; 1.70 A; B=1-222.
DR   PDB; 6KIJ; X-ray; 1.58 A; B=2-222.
DR   PDB; 6NUA; X-ray; 1.64 A; A/B=2-222.
DR   PDB; 6NUH; X-ray; 1.59 A; A=2-222.
DR   PDBsum; 2ICU; -.
DR   PDBsum; 6KBS; -.
DR   PDBsum; 6KBU; -.
DR   PDBsum; 6KBX; -.
DR   PDBsum; 6KBZ; -.
DR   PDBsum; 6KCQ; -.
DR   PDBsum; 6KIJ; -.
DR   PDBsum; 6NUA; -.
DR   PDBsum; 6NUH; -.
DR   AlphaFoldDB; P76318; -.
DR   SMR; P76318; -.
DR   BioGRID; 4261039; 9.
DR   IntAct; P76318; 14.
DR   STRING; 511145.b1931; -.
DR   jPOST; P76318; -.
DR   PaxDb; P76318; -.
DR   PRIDE; P76318; -.
DR   EnsemblBacteria; AAT48139; AAT48139; b1931.
DR   EnsemblBacteria; BAE76551; BAE76551; BAE76551.
DR   GeneID; 946435; -.
DR   KEGG; ecj:JW1916; -.
DR   KEGG; eco:b1931; -.
DR   PATRIC; fig|511145.12.peg.2013; -.
DR   EchoBASE; EB3063; -.
DR   eggNOG; COG2135; Bacteria.
DR   HOGENOM; CLU_035990_6_1_6; -.
DR   InParanoid; P76318; -.
DR   OMA; FPARYNI; -.
DR   PhylomeDB; P76318; -.
DR   BioCyc; EcoCyc:EG11662-MON; -.
DR   BioCyc; MetaCyc:EG11662-MON; -.
DR   EvolutionaryTrace; P76318; -.
DR   PRO; PR:P76318; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0018142; P:protein-DNA covalent cross-linking; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0009432; P:SOS response; IEA:UniProtKB-KW.
DR   Gene3D; 3.90.1680.10; -; 1.
DR   InterPro; IPR003738; SRAP.
DR   InterPro; IPR036590; SRAP-like.
DR   PANTHER; PTHR13604; PTHR13604; 1.
DR   Pfam; PF02586; SRAP; 1.
DR   SUPFAM; SSF143081; SSF143081; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Covalent protein-DNA linkage; DNA damage; DNA-binding;
KW   Hydrolase; Protease; Reference proteome; SOS response.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q8R1M0"
FT   CHAIN           2..222
FT                   /note="Abasic site processing protein YedK"
FT                   /id="PRO_0000169094"
FT   ACT_SITE        2
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000269|PubMed:31235915,
FT                   ECO:0000269|PubMed:31504793"
FT   SITE            105
FT                   /note="Required for sensing abasic sites"
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   SITE            160
FT                   /note="Required to stabilize abasic sites"
FT                   /evidence="ECO:0000269|PubMed:31235915"
FT   MOD_RES         2
FT                   /note="Thiazolidine linkage to a ring-opened DNA abasic
FT                   site"
FT                   /evidence="ECO:0000269|PubMed:31235915,
FT                   ECO:0000269|PubMed:31504793"
FT   MUTAGEN         2
FT                   /note="C->A: Abolished formation of the DNA-protein cross-
FT                   link. Reduced binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31235915,
FT                   ECO:0000269|PubMed:31504793"
FT   MUTAGEN         2
FT                   /note="C->S: Abolished formation of the DNA-protein cross-
FT                   link, possibly via the formation of an oxazolidine ring
FT                   with DNA that is not as stable as a thiazolidine."
FT                   /evidence="ECO:0000269|PubMed:31235915"
FT   MUTAGEN         4
FT                   /note="R->A: Reduced binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         40
FT                   /note="P->G: Reduced binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         67
FT                   /note="W->A: Abolished binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         68
FT                   /note="W->A: Abolished binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         70
FT                   /note="K->A: Slightly reduced binding to single-stranded
FT                   DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         75
FT                   /note="N->A: Reduced formation of the DNA-protein cross-
FT                   link. Reduced binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31235915,
FT                   ECO:0000269|PubMed:31504793"
FT   MUTAGEN         77
FT                   /note="R->A: Abolished binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         80
FT                   /note="T->A: Reduced binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         84
FT                   /note="S->A: Reduced binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         85
FT                   /note="R->A: Strongly reduced binding to single-stranded
FT                   DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         105
FT                   /note="E->A: Reduced formation of the DNA-protein cross-
FT                   link. Increased binding to single-stranded DNA and further
FT                   increased affinity for single-stranded DNA containing an
FT                   abasic site."
FT                   /evidence="ECO:0000269|PubMed:31235915,
FT                   ECO:0000269|PubMed:31504793"
FT   MUTAGEN         106
FT                   /note="W->A: Reduced binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         113
FT                   /note="K->A: Does not affect binding to single-stranded
FT                   DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         149
FT                   /note="T->A: Reduced formation of the DNA-protein cross-
FT                   link. Abolished binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   MUTAGEN         160
FT                   /note="H->A: Reduced formation of the DNA-protein cross-
FT                   link. Slightly increased binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31235915,
FT                   ECO:0000269|PubMed:31504793"
FT   MUTAGEN         162
FT                   /note="R->A: Abolished binding to single-stranded DNA."
FT                   /evidence="ECO:0000269|PubMed:31504793"
FT   STRAND          4..7
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           11..15
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   TURN            16..18
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           21..23
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          35..38
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          42..50
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          53..61
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          75..77
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   TURN            78..80
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           81..83
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   TURN            85..87
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           88..93
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          95..109
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          112..120
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          126..132
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           136..138
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          141..143
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          145..151
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           154..158
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          161..164
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           169..176
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           182..192
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           196..198
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   STRAND          199..203
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           206..209
FT                   /evidence="ECO:0007829|PDB:6KBX"
FT   HELIX           216..219
FT                   /evidence="ECO:0007829|PDB:6KBX"
SQ   SEQUENCE   222 AA;  24979 MW;  E203A1EA67119F1C CRC64;
     MCGRFAQSQT REDYLALLAE DIERDIPYDP EPIGRYNVAP GTKVLLLSER DEHLHLDPVF
     WGYAPGWWDK PPLINARVET AATSRMFKPL WQHGRAICFA DGWFEWKKEG DKKQPFFIYR
     ADGQPIFMAA IGSTPFERGD EAEGFLIVTA AADQGLVDIH DRRPLVLSPE AAREWMRQEI
     SGKEASEIAA SGCVPANQFS WHPVSRAVGN VKNQGAELIQ PV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024